Virtu Financial LLC Kymera Therapeutics, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$22.9 - $43.57 $117,866 - $224,254	5,147 New	5,147 $207,000
Q3 2021 Nov 12, 2021	SELL	$47.8 - $66.66 $290,863 - $405,626	-6,085 Closed	0 $0
Q2 2021 Sep 17, 2021	SELL	$31.08 - $51.95 $179,424 - $299,907	-5,773 Reduced 48.68%	6,085 $295,000
Q1 2021 May 19, 2021	BUY	$35.64 - $85.46 $422,619 - $1.01 Million	11,858 New	11,858 $461,000

181

64.3M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.21B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.